Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A48979 | 22449800 | Lab Invest | Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro. | 2012 | Details |
| A48983 | 22352842 | Br J Pharmacol | Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress. | 2012 | Details |
| A48987 | 22267590 | Gut | MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. | 2012 | Details |
| A48990 | 22214245 | Fibrogenesis Tissue Repair | Genomics and proteomics in liver fibrosis and cirrhosis. | 2012 | Details |
| A48993 | 22124143 | J Physiol | Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. | 2011 | Details |
| A48999 | 21951423 | Hepatol Res | Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice. | 2011 | Details |
| A49005 | 21604434 | Cesk Patol | [Prague Hepatology Meeting 2010--hepatopathology news]. | 2011 | Details |
| A49012 | 21338451 | Hepatol Res | Evolution of hepatic fibrosis research. | 2011 | Details |
| A49013 | 21329534 | Ned Tijdschr Geneeskd | [Diabetes mellitus and cirrhosis of the liver: a prognostically unfavourable combination]. | 2011 | Details |
| A49024 | 21088486 | Cell Cycle | Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. | 2010 | Details |
| A49026 | 20977462 | Br J Pharmacol | Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase. | 2010 | Details |
| A49027 | 20969493 | Scand J Gastroenterol | Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice. | 2010 | Details |
| A49029 | 20953207 | Acta Pharmacol Sin | Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. | 2010 | Details |
| A49030 | 20887591 | Hepatol Res | Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy. | 2010 | Details |
| A49031 | 20716942 | Oxid Med Cell Longev | Acetaldehyde adducts in alcoholic liver disease. | 2010 | Details |
| A49032 | 20706677 | Gastroenterol Res Pract | Toll-like receptor signaling and liver fibrosis. | 2010 | Details |
| A49034 | 20658448 | Diagn Interv Radiol | Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. | 2010 | Details |
| A49044 | 20192918 | Cell Biol Int | Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. | 2010 | Details |
| A49054 | 19906067 | Cancer Sci | Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. | 2009 | Details |
| A49055 | 19840249 | Liver Int | Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model. | 2009 | Details |
| A49056 | 19803220 | Rev Med Suisse | [Portal hypertension and HIV infection]. | 2009 | Details |
| A49063 | 19594758 | Br J Pharmacol | Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. | 2009 | Details |
| A49067 | 19490419 | Liver Int | Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease. | 2009 | Details |
| A49074 | 19143196 | Ter Arkh | [Porphirin metabolism in non-alcoholic steatohepatitis]. | 2008 | Details |
| A49076 | 18925608 | Hepatology | Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism. | 2008 | Details |
| A49080 | 18752754 | Zhonghua Gan Zang Bing Za Zhi | [Effect of rosiglitazone in non-alcoholic steatohepatitis associated liver fibrosis]. | 2008 | Details |
| A49084 | 18516003 | Korean J Gastroenterol | [Comparison of transient elastography and hepatic fibrosis assessed by histology in chronic liver disease]. | 2008 | Details |
| A49087 | 18443813 | Histochem Cell Biol | Intermediate filament cytoskeleton of the liver in health and disease. | 2008 | Details |
| A49088 | 18410556 | Aliment Pharmacol Ther | Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. | 2008 | Details |
| A49091 | 18336675 | J Gastroenterol Hepatol | Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. | 2008 | Details |
| A49097 | 17919273 | Aliment Pharmacol Ther | Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. | 2007 | Details |
| A49100 | 17567477 | J Gastroenterol Hepatol | Blockade of renin-angiotensin system in antifibrotic therapy. | 2007 | Details |
| A49104 | 17587244 | Pathol Int | Minute scirrhous hepatocellular carcinomas undergoing different carcinogenetic processes. | 2007 | Details |
| A49107 | 17406752 | Arq Gastroenterol | [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection]. | 2007 | Details |
| A49108 | 17374528 | Clin Chim Acta | Non-invasive assessment of chronic liver and gastric diseases. | 2007 | Details |
| A49110 | 17339254 | Gut | Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis. | 2007 | Details |
| A49113 | 17298297 | Expert Opin Ther Targets | Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases. | 2007 | Details |
| A49128 | 16508291 | Dig Dis | Molecular mechanisms of alcohol-induced hepatic fibrosis. | 2005 | Details |
| A49158 | 16020491 | Gut | Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. | 2005 | Details |
| A49164 | 15716019 | Hepatol Res | Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan. | 2005 | Details |
| A49169 | 15641470 | Gac Med Mex | [Obesity and steatohepatitis. Histologic aspects]. | 2005 | Details |
| A49173 | 15566507 | Liver Int | Clinical significance of elevated alanine aminotransferase in blood donors: a follow-up study. | 2004 | Details |
| A49177 | 15464253 | J Hepatol | Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. | 2004 | Details |
| A49179 | 15368443 | Hepatology | Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. | 2004 | Details |
| A49187 | 14987322 | Aliment Pharmacol Ther | Metformin in the treatment of patients with non-alcoholic steatohepatitis. | 2004 | Details |
| A49193 | 14520852 | Ter Arkh | [Clinicomorphological changes of liver in atherogenic dyslipidemia and after treatment with statins]. | 2003 | Details |
| A49203 | 35830037 | Arq Gastroenterol | OBSTRUCTIVE SLEEP APNEA SYNDROME RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH OBESITY AND PRESENCE OF NASH. | 2022 | Details |
| A49205 | 35829867 | Hepatol Int | Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male. | 2022 | Details |
| A49206 | 35829866 | Hepatol Int | Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study. | 2022 | Details |
| A49207 | 35822302 | Hepatology | Validation of the new 2021 EASL algorithm for the non-invasive diagnosis of advanced fibrosis in NAFLD. | 2022 | Details |
| A49208 | 35822119 | JGH Open | Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study. | 2022 | Details |
| A49211 | 35821256 | Gene Ther | Loss of RAGE prevents chronic intermittent hypoxia-induced nonalcoholic fatty liver disease via blockade of NF-кB pathway. | 2022 | Details |
| A49215 | 35820779 | Gut | Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis. | 2022 | Details |
| A49221 | 35817360 | Pharmacol Res | Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury. | 2022 | Details |
| A49224 | 35816948 | Diabetes Metab Syndr | Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD. | 2022 | Details |
| A49227 | 35814522 | J Clin Exp Hepatol | Overview of Complications in Cirrhosis. | 2022 | Details |
| A49230 | 35814516 | J Clin Exp Hepatol | Pharmacotherapeutic Impact on Nonalcoholic Steatohepatitis Histology: A Systematic Review and Network Meta-analysis. | 2022 | Details |
| A49234 | 35813333 | Ann Transl Med | Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice. | 2022 | Details |
| A49238 | 35812025 | Frontline Gastroenterol | Histopathologist and clinician interface in diagnosis and management of autoimmune hepatitis. | 2022 | Details |
| A49239 | 35812024 | Frontline Gastroenterol | What's new in non-alcoholic fatty liver disease? | 2022 | Details |
| A49242 | 35811919 | ACS Omega | Identify Functional lncRNAs in Nonalcoholic Fatty Liver Disease by Constructing a ceRNA Network. | 2022 | Details |
| A49244 | 35811662 | Dis Markers | Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49246 | 35811319 | BMC Gastroenterol | Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey. | 2022 | Details |
| A49248 | 35811043 | Clin Gastroenterol Hepatol | The prevalence and determinants of NAFLD and MAFLD and their severity in the VA primary care setting. | 2022 | Details |
| A49249 | 35811033 | Biochim Biophys Acta Mol Basis Dis | Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response. | 2022 | Details |
| A49253 | 35809234 | Hepatology | Machine Learning Models Are Superior to Non-Invasive Tests in Identifying Clinically Significant Stages of NAFLD and NAFLD-Related Cirrhosis. | 2022 | Details |
| A49254 | 35808928 | J Clin Lab Anal | Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease. | 2022 | Details |
| A49258 | 35807924 | Nutrients | Changes in Biomarkers of Non-Alcoholic Fatty Liver Disease (NAFLD) upon Access to Avocados in Hispanic/Latino Adults: Secondary Data Analysis of a Cluster Randomized Controlled Trial. | 2022 | Details |
| A49264 | 35806450 | Int J Mol Sci | The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage. | 2022 | Details |
| A49269 | 35806284 | Int J Mol Sci | Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49272 | 35805998 | Int J Mol Sci | Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD). | 2022 | Details |
| A49277 | 35803990 | Sci Rep | Association between organochlorine pesticides and nonalcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004. | 2022 | Details |
| A49278 | 35803474 | Environ Toxicol Pharmacol | Multiomics analysis of the impact of polychlorinated biphenyls on environmental liver disease in a mouse model. | 2022 | Details |
| A49281 | 35802264 | Clin Exp Med | MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases. | 2022 | Details |
| A49283 | 35800999 | Ann Surg Treat Res | Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective. | 2022 | Details |
| A49287 | 35799983 | Biochem Med (Zagreb) | Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease. | 2022 | Details |
| A49289 | 35798791 | Sci Rep | Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity. | 2022 | Details |
| A49290 | 35798217 | Diabetes Res Clin Pract | Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis. | 2022 | Details |
| A49296 | 35796150 | J Intern Med | Current treatment of non-alcoholic fatty liver disease. | 2022 | Details |
| A49297 | 35796003 | Int J Mol Med | Role of Ca2+ channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review). | 2022 | Details |
| A49298 | 35795637 | Front Med (Lausanne) | A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population. | 2022 | Details |
| A49305 | 35793386 | Scand J Gastroenterol | Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals. | 2022 | Details |
| A49311 | 35791792 | Rev Esp Enferm Dig | Liver stiffness accuracy by MR elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort. | 2022 | Details |
| A49316 | 35790343 | J Gastroenterol Hepatol | The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan. | 2022 | Details |
| A49317 | 35790023 | Diabet Med | Banting Memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: partners in crime'. | 2022 | Details |
| A49319 | 35789846 | iScience | M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model. | 2022 | Details |
| A49321 | 35789393 | Toxicol Sci | Increased Renal Expression of Complement Components in Patients with Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination. | 2022 | Details |
| A49322 | 35789194 | Liver Int | Impact of Liver Fibrosis Score on the incidence of stroke: A cohort study. | 2022 | Details |
| A49323 | 35788349 | Gastroenterology | Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants. | 2022 | Details |
| A49325 | 35788089 | Chin Med J (Engl) | Bile acids and sphingolipids in non-alcoholic fatty liver disease. | 2022 | Details |
| A49326 | 35787975 | Cell Mol Gastroenterol Hepatol | Cell-specific deletion of NLRP3 inflammasome identifies myeloid cells as key drivers of liver inflammation and fibrosis in murine steatohepatitis. | 2022 | Details |
| A49329 | 35787355 | Endocrinol Diabetes Nutr (Engl Ed) | The practical utility of non-invasive indices in metabolic hepatic steatosis. | 2022 | Details |
| A49337 | 35784557 | Front Endocrinol (Lausanne) | Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis. | 2022 | Details |
| A49338 | 35784533 | Front Endocrinol (Lausanne) | Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A49339 | 35784296 | Front Immunol | Liver Fibrosis in Primary Sjögren's Syndrome. | 2022 | Details |
| A49340 | 35783879 | Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. | 2022 | Details |
| A49341 | 35783474 | Hepatol Forum | Role of serum hyaluronic acid in predicting necroinflammatory activity of the nonalcoholic fatty liver disease. | 2022 | Details |
| A49347 | 35782375 | Hepatol Forum | Prevention of hepatocellular carcinoma and monitoring of high-risk patients. | 2022 | Details |
| A49348 | 35782337 | Gastroenterol Res Pract | Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49350 | 35781090 | Ann Hepatol | Safety and efficacy of dyslipidemia treatment in NAFLD Patients: a Meta-analysis of randomized controlled trials. | 2022 | Details |